Biotech Values

[DewDiligence]

>Biotech companies are being rapidly divided among three distinct classes: growing biotechs worth more than a billion dollars, survivors with money in the bank and a growing segment of downsizing small and mid-sized companies.<

I would add a fourth class consisting of the companies who couldn’t obtain funding and were forced to declare bankruptcy (#msg-33749911, #msg-33720220).